The use of microtracers in food‐effect trials: An alternative study design for toxic drugs with long half‐lives exemplified by the case for alectinib
Abstract The traditional design of food‐effect studies has a high patient burden for toxic drugs with long half‐lives (e.g., anticancer agents). Microtracers could be used to assess food‐effect in patients without influencing their ongoing treatment. The feasibility of a microtracer food‐effect stud...
Saved in:
Main Authors: | L. T. van derHeijden (Author), N. Steeghs (Author), J. H. Beijnen (Author), A. D. R. Huitema (Author), T. P. C. Dorlo (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A naïve pooled data approach for extrapolation of Phase 0 microdose trials to therapeutic dosing regimens
by: Lisa van derHeijden, et al.
Published: (2023) -
Development of Alectinib-Suspended SNEDDS for Enhanced Solubility and Dissolution
by: Eun Ji Park, et al.
Published: (2022) -
The application of Phase 0 and microtracer approaches in early clinical development: past, present, and future
by: A. F. Roffel, et al.
Published: (2024) -
CMC development of [14C]-labeled sotorasib for the conduct of microtracer human ADME study
by: Sonika Sharma, et al.
Published: (2023) -
Relative bioavailability and food effect study of an oral suspension of alectinib in healthy volunteers using venipuncture and capillary microsampling
by: Stephanie N. Liu, et al.
Published: (2023)